Bethan Powell

3.8k citations
10 papers · 2.9k · 2 hit papers · h-index 6

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 2%
    • PARP inhibition in cancer therapy
    • Cancer-related Molecular Pathways

Papers in

    • BRCA gene mutations in cancer 4
    • Genomic variations and chromosomal abnormalities 2
    • Ovarian cancer diagnosis and treatment 5

Bethan Powell

10 papers receiving 2.9k citations

Bethan Powell's Hit Papers

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial 2010 · 1.7k citations
1.7k0+9+18Years since publication50010001.5k

Peers

Bethan Powell
Comparison fields: 5 of 95
  • Reproductive Medicine 663
  • Oncology 1.6k
  • Cancer Research 594
  • Molecular Biology 1.8k
  • Genetics 708
Replace Rebecca Kristeleit with:
Rebecca Kristeleit United Kingdom
Rita K. Schmutzler Germany
David S. Boss Netherlands
Rita K. Schmutzler Germany
Darren Hodgson United Kingdom
Rachel Brough United Kingdom
Kirsten M. Timms United States
Elizabeth Lowe United States
Rosemary L. Balleine Australia
Yvette Drew United Kingdom
Bethan Powell relative to Rebecca Kristeleit United Kingdom Rebecca Kristeleit's profile →
Citations per field
00.5×1.5×2.4×
Rebecca Kristeleit · 1×
Citations per year

Countries citing papers authored by Bethan Powell

Since Specialization
Citations

This map shows the geographic impact of Bethan Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bethan Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bethan Powell more than expected).

Fields of papers citing papers by Bethan Powell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bethan Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bethan Powell. The network helps show where Bethan Powell may publish in the future.

Co-authors

The 25 scholars most cited alongside Bethan Powell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bethan Powell Line = papers co-authored together Bethan Powell links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
Hit paper breakdown →
20101742
2
PIK3CA is implicated as an oncogene in ovarian cancer
Hit paper breakdown →
1999925
3 2004144
4
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.
200098
5 201917
6 20168
7 20204
8 20251
9 20171
10 20151

About Bethan Powell

Bethan Powell is a scholar working on Genetics, Reproductive Medicine, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 10 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (5 papers), BRCA gene mutations in cancer (4 papers), Cancer Genomics and Diagnostics (2 papers), Genetic factors in colorectal cancer (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), PARP inhibition in cancer therapy (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Reproductive Medicine (663 citations), Oncology (1.6k citations), Cancer Research (594 citations), Molecular Biology (1.8k citations) and Genetics (708 citations). Bethan Powell has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Mark Wickens, Karen H. Lu, Niklas Loman, Ursula A. Matulonis, Katherine M. Bell‐McGuinn, Rita K. Schmutzler, Ana Oaknin, Jeffrey N. Weitzel, Richard T. Penson and Andrew Tutt. Their work appears in journals such as Nature Genetics, PLoS Medicine, Journal of Clinical Oncology, Clinical Breast Cancer and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact